The company's financial stability is increasingly constrained, characterized by a debt-to-equity ratio of 1.76 and a current ratio that has tightened to 1.19 as of 2026Q1.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Apr'00 | Apr'99 |
|---|
| Total Current Assets | 168.34M | 213.6M | 102.65M | 179.47M | 281.33M | 271.17M | 299.19M | 295.39M | 366.42M | 209M | 235.2M | 358.97M | 427.7M | 315.7M | 218M | 214.5M | 190.44M | 199.95M | 225.04M | 186.34M | 154.75M | 127.71M | 125.82M | 114.63M | 145.44M | 83.88M | 93.44M | 186.75M |
| Cash & Short-Term Investments | 126.67M | 160.28M | 53.02M | 109.37M | 178.33M | 153.79M | 165.89M | 182.74M | 236.97M | 83.05M | 108.66M | 241.53M | 301.21M | 174.56M | 70.22M | 47.47M | 40.53M | 46.14M | 47.32M | 39.82M | 37.5M | 31.48M | 35.16M | 23.44M | 57.53M | 23.34M | 44.5M | 19.52M |
| Cash Only | 126.67M | 160.28M | 53.02M | 109.37M | 178.33M | 153.79M | 165.89M | 182.74M | 236.97M | 83.05M | 108.66M | 241.53M | 301.21M | 174.56M | 70.22M | 47.47M | 40.53M | 46.14M | 47.32M | 39.82M | 37.5M | 31.48M | 35.16M | 23.44M | 57.53M | 23.34M | 44.5M | 19.52M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 16.86M | 16.38M | 14.43M | 14.94M | 24.27M | 29.32M | 34.55M | 30.52M | 27.25M | 23.91M | 27.52M | 29.28M | 31.96M | 36.25M | 37.36M | 47.17M | 43.72M | 39.62M | 37.85M | 42.37M | 40.32M | 28.04M | 21.78M | 18.55M | 19.11M | 13.62M | 22.15M | 15.67M |
| Days Sales Outstanding | 7.89 | 8.41 | 6.7 | 6.13 | 8.52 | 8.84 | 9.15 | 7.88 | 6.57 | 6.68 | 8.62 | 9.18 | 7.88 | 7.67 | 7.47 | 9.47 | 10.99 | 10.34 | 9 | 10.54 | 11.93 | 8.89 | 7.76 | 7.17 | 8.61 | 7.97 | 20.23 | 14.31 |
| Inventory | 0 | 0 | 0 | 68K | 20.53M | 30.57M | 39.46M | 27.2M | 25.85M | 31.73M | 32.63M | 27.84M | 32.38M | 40.94M | 46.85M | 53.44M | 40.57M | 32.49M | 40.12M | 44.61M | 38.55M | 31.68M | 32.93M | 39.11M | 38.58M | 26.2M | 15.04M | 7.58M |
| Days Inventory Outstanding | - | - | - | 0.07 | 17.91 | 23.03 | 23.99 | 15.85 | 14.57 | 18.85 | 20.55 | 17.21 | 17.45 | 20.67 | 22.54 | 25.26 | 22.39 | 17.67 | 20.9 | 24.92 | 25.25 | 22.21 | 24.67 | 32.41 | 38.03 | 33.39 | 27.27 | 13.74 |
| Other Current Assets | 16.35M | 19.57M | 18.55M | 19.58M | 30.83M | 21.03M | 23.61M | 30.58M | 42.35M | 26.8M | 30.88M | 15.44M | 23.74M | 24.46M | 57.46M | 63.37M | 19.8M | 18.24M | 69.97M | 20.1M | 3.44M | 10.88M | 4.32M | 3.97M | 4.22M | 0 | 648K | 94K |
| Total Non-Current Assets | 712.73M | 733.15M | 447.63M | 802.56M | 747.1M | 1.16B | 1.18B | 1.2B | 1.05B | 1.04B | 1.04B | 1.06B | 1.09B | 1.09B | 1B | 907.1M | 901.54M | 887.56M | 881.71M | 859.88M | 847.65M | 707.78M | 690.37M | 655.06M | 464.46M | 398.97M | 252.78M | 184.68M |
| Property, Plant & Equipment | 10.03M | 11.05M | 57.84M | 72.01M | 103.92M | 127.12M | 171.04M | 206.05M | 52.2M | 48M | 49.6M | 58.19M | 74.6M | 87.1M | 71.8M | 41.1M | 30.93M | 36.04M | 37.51M | 37.65M | 31.03M | 20.77M | 17.48M | 15.75M | 12.36M | 10.72M | 8.14M | 8.72M |
| Fixed Asset Turnover | 59.69x | 64.32x | 13.59x | 12.35x | 10.01x | 9.53x | 8.06x | 6.86x | 29.01x | 27.23x | 23.49x | 20.01x | 19.84x | 19.79x | 25.44x | 44.26x | 46.94x | 38.82x | 40.95x | 38.97x | 39.74x | 55.42x | 58.63x | 59.94x | 65.53x | 58.17x | 49.06x | 45.80x |
| Goodwill | 200M | 200.13M | 239.58M | 243.44M | 156M | 157.37M | 155.62M | 157.92M | 152.52M | 156.28M | 166.14M | 159.33M | 106.82M | 79.29M | 59.41M | 50.01M | 51.42M | 51.37M | 51.3M | 51.36M | 51.33M | 51.3M | 25.13M | 0 | 0 | 234.3M | 150.9M | 143.71M |
| Intangible Assets | 471.53M | 490.66M | 115.76M | 449.73M | 450.05M | 846.32M | 825.56M | 812.48M | 808.3M | 800.58M | 807.23M | 813.66M | 867.91M | 882.13M | 839.49M | 801.49M | 795.83M | 790.25M | 777.1M | 751.73M | 712.93M | 564.44M | 562.84M | 522.49M | 310.55M | 6.86M | 6.65M | 8.11M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16.23M | -143.59M | -175.12M | 17.69M | 9.12M | 17.56M | 4.74M | -15.92M | -6.41M | -1.54M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.49M | 5.6M | 19.16M |
| Other Non-Current Assets | 14.91M | 14.82M | 17.75M | 17.68M | 14.88M | 15.69M | 16.14M | 12.16M | 35.1M | 32.1M | 12.8M | 6.72M | 5.34M | 2.68M | 3.4M | 5.81M | 9.97M | 3.33M | 7.7M | 9.22M | 8.42M | 9.34M | 6.96M | 7.02M | 10.07M | 1.31M | 14.28M | 830K |
| Total Assets | 881.07M | 946.76M | 550.28M | 982.03M | 1.03B | 1.43B | 1.48B | 1.5B | 1.41B | 1.25B | 1.27B | 1.42B | 1.52B | 1.41B | 1.22B | 1.12B | 1.09B | 1.09B | 1.11B | 1.05B | 1B | 835.49M | 816.19M | 769.69M | 609.9M | 482.85M | 346.22M | 371.43M |
| Asset Turnover | 0.72x | 0.75x | 1.43x | 0.91x | 1.01x | 0.85x | 0.93x | 0.94x | 1.07x | 1.05x | 0.92x | 0.82x | 0.98x | 1.22x | 1.50x | 1.62x | 1.33x | 1.29x | 1.39x | 1.40x | 1.23x | 1.38x | 1.26x | 1.23x | 1.33x | 1.29x | 1.15x | 1.08x |
| Asset Growth % | 238.94% | 72.05% | -43.97% | -4.51% | -28.03% | -3.53% | -1.14% | 5.92% | 13.53% | -1.97% | -10.62% | -6.15% | 7.54% | 15.62% | 8.65% | 2.71% | 0.41% | -1.74% | 5.79% | 4.37% | 19.98% | 2.37% | 6.04% | 26.2% | 26.31% | 39.46% | -6.79% | - |
| Total Current Liabilities | 141.09M | 126.54M | 173.33M | 205.46M | 196.56M | 229.13M | 340.1M | 394.07M | 341.32M | 343M | 292.4M | 503.13M | 378.3M | 345.8M | 447.9M | 494.2M | 539.13M | 536.05M | 495.12M | 358.43M | 236.53M | 165.89M | 152.62M | 134.17M | 123.38M | 108.01M | 83.24M | 95.55M |
| Accounts Payable | 17.08M | 9.21M | 17.8M | 18.51M | 18.89M | 22.44M | 23.05M | 29.06M | 27.1M | 24.36M | 40.64M | 38.23M | 54.47M | 45.5M | 49.35M | 60.81M | 39.59M | 28.37M | 33.15M | 42.68M | 31.89M | 19.71M | 20.76M | 22.29M | 20.25M | 17.7M | 11.99M | 12.36M |
| Days Payables Outstanding | 20.12 | 16.8 | 25.7 | 18.75 | 16.48 | 16.91 | 14.02 | 16.93 | 15.27 | 14.47 | 25.6 | 23.64 | 29.35 | 22.97 | 23.74 | 28.75 | 21.85 | 15.43 | 17.27 | 23.85 | 20.89 | 13.82 | 15.56 | 18.47 | 19.96 | 22.55 | 21.73 | 22.41 |
| Short-Term Debt | 27.99M | 0 | 0 | 0 | 0 | 0 | 77M | 96.25M | 77M | 82.75M | 21M | 213.32M | 24M | 30M | 114.69M | 124.93M | 197.52M | 215M | 162.5M | 45.63M | 18.92M | 4.7M | 3M | 15.55M | 18.36M | 18.59M | 15.85M | 24.1M |
| Deferred Revenue (Current) | 112.9M | 28.57M | 31.66M | 33.97M | 32.16M | 45.85M | 50.48M | 60.61M | 53.5M | 74.33M | 62.88M | 61.6M | 66.19M | 76.33M | 86.16M | 83.76M | 73.69M | 68.47M | 60.05M | 59.39M | 43.44M | 38.49M | 27.08M | 16.53M | 15.43M | 13.02M | 49.57M | 52.33M |
| Other Current Liabilities | 38.6M | 0 | 0 | 0 | 0 | 14.67M | 28.28M | 21.6M | 70.18M | 99.41M | 118.23M | 142.94M | 222.25M | 128.18M | 141.16M | 162M | 40.78M | 70.23M | 186.27M | 100.57M | 32.58M | 20.96M | 39.53M | 24.62M | 30.89M | 6.25M | 5.84M | 13.24M |
| Current Ratio | 1.19x | 1.69x | 0.59x | 0.87x | 1.43x | 1.18x | 0.88x | 0.75x | 1.07x | 0.61x | 0.80x | 0.71x | 1.13x | 0.91x | 0.49x | 0.43x | 0.35x | 0.37x | 0.45x | 0.52x | 0.65x | 0.77x | 0.82x | 0.85x | 1.18x | 0.78x | 1.12x | 1.95x |
| Quick Ratio | 1.19x | 1.69x | 0.59x | 0.87x | 1.33x | 1.05x | 0.76x | 0.68x | 1.00x | 0.52x | 0.69x | 0.66x | 1.04x | 0.79x | 0.38x | 0.33x | 0.28x | 0.31x | 0.37x | 0.40x | 0.49x | 0.58x | 0.61x | 0.56x | 0.87x | 0.53x | 0.94x | 1.88x |
| Cash Conversion Cycle | -12.23 | - | - | -12.55 | 9.95 | 14.96 | 19.13 | 6.8 | 5.87 | 11.06 | 3.58 | 2.76 | -4.02 | 5.37 | 6.26 | 5.98 | 11.53 | 12.58 | 12.63 | 11.62 | 16.29 | 17.28 | 16.87 | 21.11 | 26.69 | 18.81 | 25.77 | 5.65 |
| Total Non-Current Liabilities | 474.41M | 502.15M | 1.49B | 1.54B | 1.52B | 1.66B | 1.69B | 1.79B | 1.88B | 1.92B | 2.19B | 2.21B | 2.53B | 2.54B | 2.44B | 1.04B | 1.24B | 1.28B | 1.5B | 1.61B | 834.23M | 750.25M | 467.13M | 454.33M | 439.97M | 488.36M | 485.75M | 26.93M |
| Long-Term Debt | 438.63M | 465.47M | 1.43B | 1.43B | 1.42B | 1.42B | 1.41B | 1.48B | 1.67B | 1.74B | 1.98B | 2B | 2.33B | 2.36B | 2.29B | 926.87M | 1.17B | 1.24B | 1.49B | 1.6B | 830.24M | 741.42M | 466.13M | 454.32M | 436.32M | 458.32M | 456.53M | 15.5M |
| Capital Lease Obligations | 8.26M | 1.89M | 44.32M | 53.46M | 68.1M | 78.16M | 101.56M | 128.46M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 155.5M | 34.02M | 14.76M | 41.99M | 25.08M | 157.72M | 173.71M | 175.24M | 208.55M | 173.9M | 200.2M | 159.54M | 188.4M | 179.7M | 129.4M | 100.7M | 62.81M | 34.62M | 2.69M | 1.79M | 26K | 26K | 715K | 3.26M | 3.26M | 3.17M | 3.11M | 8.23M |
| Other Non-Current Liabilities | 468K | 771K | 1.59M | 15.74M | 2.19M | 2.23M | 5.21M | 6.17M | 18.29M | 30.29M | 25.05M | 23.88M | 16.88M | 14.65M | 15.11M | 9.6M | 13.21M | 12.1M | 11.46M | 9.83M | 3.99M | 8.8M | 285K | -822K | 102K | 870K | 121K | 3.2M |
| Total Liabilities | 615.5M | 628.69M | 1.66B | 1.74B | 1.71B | 1.89B | 2.03B | 2.18B | 2.22B | 2.26B | 2.48B | 2.71B | 2.91B | 2.88B | 2.88B | 1.53B | 1.78B | 1.82B | 1.99B | 1.97B | 1.07B | 916.14M | 619.75M | 588.5M | 563.36M | 596.37M | 569M | 122.49M |
| Total Debt | 468.19M | 468.62M | 1.48B | 1.49B | 1.51B | 1.52B | 1.62B | 1.74B | 1.75B | 1.74B | 1.98B | 2.23B | 2.33B | 2.36B | 2.29B | 926.9M | 1.37B | 1.45B | 1.64B | 1.65B | 849.16M | 746.13M | 469.13M | 469.87M | 454.68M | 476.91M | 472.38M | 39.6M |
| Net Debt | 341.53M | 308.34M | 1.43B | 1.38B | 1.33B | 1.36B | 1.45B | 1.56B | 1.51B | 1.66B | 1.87B | 1.99B | 2.03B | 2.18B | 2.22B | 879.43M | 1.32B | 1.41B | 1.59B | 1.61B | 811.65M | 714.65M | 433.97M | 446.43M | 397.15M | 453.57M | 427.88M | 20.09M |
| Debt / Equity | 1.76x | 1.47x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.39x | 2.59x | 9.77x | - | - | 0.16x |
| Debt / EBITDA | 4.78x | 4.11x | 12.72x | 18.99x | - | 6.19x | 6.06x | 5.22x | 4.03x | 5.47x | 7.82x | 10.10x | 7.28x | 4.66x | 4.30x | 1.61x | 3.26x | 3.78x | 3.63x | 3.61x | 2.15x | 2.36x | 1.48x | 1.45x | 1.50x | 2.29x | 4.82x | 0.42x |
| Net Debt / EBITDA | 3.49x | 2.70x | 12.27x | 17.60x | - | 5.56x | 5.43x | 4.67x | 3.49x | 5.21x | 7.39x | 9.01x | 6.34x | 4.32x | 4.17x | 1.52x | 3.16x | 3.66x | 3.53x | 3.52x | 2.06x | 2.26x | 1.37x | 1.38x | 1.31x | 2.18x | 4.36x | 0.21x |
| Interest Coverage | 24.27x | 18.21x | -2.17x | 0.23x | -3.52x | 1.88x | 1.75x | 2.12x | 2.71x | 2.29x | 1.73x | 1.46x | 2.49x | 4.16x | 5.61x | 9.06x | 5.11x | 5.35x | 4.92x | 4.00x | 7.71x | 11.92x | 10.98x | 2.36x | - | 2.32x | 2.15x | 77.14x |
| Total Equity | 265.57M | 318.07M | -1.11B | -761.09M | -685.78M | -456.4M | -548.21M | -685.54M | -805.03M | -1.01B | -1.2B | -1.29B | -1.39B | -1.47B | -1.67B | -409.8M | -690.72M | -733.27M | -887.52M | -926.33M | -68.37M | -80.65M | 196.44M | 181.19M | 46.55M | -113.52M | -222.78M | 248.95M |
| Equity Growth % | 514.65% | 128.54% | -46.42% | -10.98% | -50.26% | 16.75% | 20.03% | 14.84% | 20.41% | 15.91% | 6.44% | 7.21% | 6.03% | 11.46% | -306.42% | 40.67% | 5.8% | 17.38% | 4.19% | -1254.94% | 15.23% | -141.06% | 8.42% | 289.25% | 141.01% | 49.04% | -189.49% | - |
| Book Value per Share | 26.57 | 31.83 | -14.00 | -9.93 | -9.75 | -6.45 | -7.83 | -9.86 | -11.48 | -14.82 | -18.25 | -21.80 | -24.44 | -26.15 | -27.34 | -5.53 | -9.10 | -9.51 | -11.31 | -11.42 | -0.69 | -0.77 | 1.84 | 1.65 | 0.43 | -1.02 | -9.62 | 10.75 |
| Total Shareholders' Equity | 265.57M | 318.07M | -1.11B | -761.09M | -685.78M | -456.4M | -548.21M | -685.54M | -808.94M | -1.02B | -1.21B | -1.29B | -1.39B | -1.47B | -1.67B | -409.8M | -694.77M | -736.51M | -887.52M | -926.33M | -68.37M | -80.65M | 196.44M | 181.19M | 46.55M | -113.52M | -222.78M | 248.95M |
| Common Stock | 379.31M | 378.78M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -114.09M | -62.09M | 1.94B | 2.31B | 2.42B | 2.68B | 2.62B | 2.5B | 2.38B | 2.2B | 2.06B | 1.99B | 1.88B | 1.77B | 1.6B | 1.38B | 1.1B | 1.26B | 1.13B | 950.21M | 770.54M | 617.47M | 413.43M | 223.56M | 73.48M | -74M | -216.51M | -231.66M |
| Treasury Stock | 0 | 0 | -3.02B | -3.06B | -3.1B | -3.12B | -3.14B | -3.16B | -3.18B | -3.21B | -3.24B | -3.25B | -3.25B | -3.26B | -3.28B | -1.79B | -1.79B | -1.68B | -1.68B | -1.57B | -540.32M | -390.86M | -222.55M | -48.42M | -23.06M | -26.2M | 0 | 0 |
| Accumulated OCI | 360K | 1.39M | -25.83M | -11.3M | -5.47M | -18.6M | -25.15M | -27.35M | -15.76M | -10.47M | -27.12M | -37.27M | -19.56M | 8.52M | 12.86M | 5.6M | -4.52M | -7.68M | -333.77M | -306.49M | -298.59M | -307.26M | 5.56M | 6.05M | -3.87M | -13.32M | -6.27M | -2.45M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.91M | 4.47M | 4.7M | 4.45M | 5.55M | 0 | 0 | 0 | 4.04M | 3.24M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital structure insolvency risk
As reported in recent financial filings, WW's total assets have declined from $982.0M in 2023Q4 to $881.1M in 2026Q1, reflecting a persistent contraction in the company's resource base that suggests a weakening competitive position and limited capacity to absorb further operational shocks.
The consistent decline in total assets alongside a negative retained earnings balance of $114.1M in 2026Q1 indicates that the company is consuming its capital base to fund ongoing operations. This trajectory suggests that the business model is struggling to achieve the scale necessary to stabilize its financial foundation.
Based on the most recent quarterly data, the company maintains a debt-to-equity ratio of 1.76, which, when viewed alongside the $468.2M in total debt, highlights a precarious leverage profile that may limit strategic flexibility in a high-interest rate environment.
The presence of significant debt relative to a shrinking equity base suggests that the company's capital structure is highly sensitive to cash flow volatility. Investors should monitor whether the current debt load can be serviced without further dilutive equity actions or restrictive refinancing terms.
According to the 2026Q1 balance sheet, the current ratio has compressed to 1.19, down from 1.69 in 2025Q4, signaling a diminishing buffer of liquid assets available to meet short-term obligations as the company navigates its clinical pivot.
The rapid decline in cash reserves from $160.3M in 2025Q4 to $126.7M in 2026Q1 suggests that the company is burning through its liquidity at an unsustainable rate. This trend warrants further investigation into the company's ability to maintain operations without external capital injections.
As indicated by the $200.0M in goodwill reported in 2026Q1, a significant portion of the company's asset base remains tied to intangible valuations that may be subject to impairment if the clinical pivot fails to generate expected returns.
The reliance on goodwill as a major component of total assets suggests that the balance sheet may be overstating the tangible value of the firm. If the market resonance of the brand continues to decline, these intangibles could face write-downs, further pressuring the already strained equity position.
Quick answers to the most common questions about buying WW stock.
As of 2025, WW International, Inc. (WW) had total assets of $946.8M including $213.6M in current assets.
WW International, Inc. (WW) carries total debt of $468.6M, offset by $160.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
WW International, Inc. (WW) has total shareholders' equity (book value) of $318.1M ($31.83 book value per share). Book value represents the net worth of the company belonging to common stock holders.
WW International, Inc. (WW) reported a current ratio of 1.69x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.